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Hereditary ferritinopathyHereditary ferritinopathy (HF) is a neurodegenerative disease characterized by intracellular ferritin inclusion
bodies (IBs) and iron accumulation throughout the central nervous system. Ferritin IBs are composed of
mutant ferritin light chain as well as wild-type light (Wt-FTL) and heavy chain (FTH1) polypeptides. In vitro
studies have shown that the mutant light chain polypeptide p.Phe167SerfsX26 (Mt-FTL) forms soluble ferritin
24-mer homopolymers having a speciﬁc structural disruption that explains its functional problems of reduced
ability to incorporate iron and aggregation during iron loading. However, because ferritins are usually 24-mer
heteropolymers and all three polypeptides are found in IBs, we investigated the properties of Mt-FTL/FTH1 and
Mt-FTL/Wt-FTL heteropolymeric ferritins. We show here the facile assembly of Mt-FTL and FTH1 subunits into
soluble ferritin heteropolymers, but their ability to incorporate iron was signiﬁcantly reduced relative to Wt-
FTL/FTH1 heteropolymers. In addition, Mt-FTL/FTH1 heteropolymers formed aggregates during iron loading,
contrasting Wt-FTL/FTH1 heteropolymers and similar to what was seen for Mt-FTL homopolymers. The
resulting precipitate contained both Mt-FTL and FTH1 polypeptides as do ferritin IBs in patients with HF. The
presence of Mt-FTL subunits in Mt-FTL/Wt-FTL heteropolymers also caused iron loading-induced aggregation
relative to Wt-FTL homopolymers, with the precipitate containing Mt- and Wt-FTL polypeptides again
paralleling HF. Our data demonstrate that co-assembly with wild-type subunits does not circumvent the
functional problems caused by mutant subunits. Furthermore, the functional problems characterized here in
heteropolymers that contain mutant subunits parallel those problems previously reported in homopolymers
composed exclusively of mutant subunits, which strongly suggests that the structural disruption
characterized previously in Mt-FTL homopolymers occurs in a similar manner and to a signiﬁcant extent in
both Mt-FTL/FTH1 and Mt-FTL/Wt-FTL heteropolymers.ype) ferritin heavy chain; Wt-
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Ferritin is the main cellular iron storage protein and plays a pivotal
role in iron homeostasis. There is increasing evidence that iron is
involved in the mechanisms that underlie many neurodegenerativediseases [1]. Mammalian ferritin forms an~480 kDa spherical shell
(~12 nm of outer and 7 nm inner diameter) from 24 self-assembling
subunits creating eight 3-fold pores, which constitute the iron entry
pathways, and six 4-fold pores, which are smaller and perhaps sealed
[2]. Ferritin oxidizes ferrous iron (Fe(II)) to ferric iron (Fe(III)), which
is then sequestered in its interior as an iron-oxy biomineral matrix of
up to 4,500 iron atoms. In doing so it performs a cellular detoxiﬁcation
role in helping control free iron levels and reducing radical-mediated
damage.
Ferritin is usually found as a 24-mer heteropolymer with different
ratios of light (FTL) and heavy chain (FTH1) subunits associated with
tissue speciﬁc roles, although FTL homopolymers also occur in vivo [2].
The FTH1 subunit has ferroxidase activity (initiating the oxidation of
Fe(II)), while the FTL subunit enhances iron nucleation (leading to
biomineral formation) [2] and increases protein stability against
elevated temperature and denaturants [3,4]. The FTL subunit also
protects the heteropolymer against aggregation and precipitation that
may occur while incubating with Fe(II) during iron incorporation, i.e.,
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sively of FTL subunits can incorporate iron, but more slowly than the
heteropolymer [2,5]. FTL and FTH1 polypeptides are 54% identical in
sequence with speciﬁc replacements related to function. Both
polypeptides fold into subunits composed of a bundle of 4 parallel,
longer α helices (A, B, C, D) and a C-terminus with a shorter α helix
(E). Extensive helix–helix interactions occur between these bundles
and between the inwardly pointing E-helicies forming the 4-fold
pores [2,6]. Both subunits are so similarly shaped as to be
interchangeable in the shell [2,6].
Nucleotide duplications in exon 4 of the FTL gene [7–12] cause the
autosomal dominant neurodegenerative disease known as neurofer-
ritinopathy [7] or hereditary ferritinopathy (HF) [8,9]. HF is
characterized by the presence of intracellular ferritin inclusion bodies
(IBs) and iron accumulation throughout the central nervous and other
organ systems [8,9]. The mutations alter the C-terminal residues of
the FTL polypeptide, yielding light chains that are changed in length
and sequence to differing extents depending on the speciﬁc mutation
[13]. We have previously shown that the mutant FTL polypeptide p.
Phe167SerfsX26 (Mt-FTL) assembled into soluble 24-mer homopol-
ymeric shells that were very similar to the Wt-FTL homopolymers in
size, spherical shape, and overall structure (Fig. 1a) [14,15]. Relative to
Wt-FTL, soluble Mt-FTL homopolymers showed reduced iron incor-
poration and iron loading-induced precipitation from solution as iron
concentration was increased [14,15]. Structurally, we found that all 24
of the subunits in the Mt-FTL homopolymers lost the conformational
integrity of their E helices, which in turn caused localized but
substantial disruption of all six 4-fold pores making them unstable
and leaky (Fig. 1b) [14,15]. We proposed that this unraveling and
extension of the C-terminal portion of the Mt-FTL subunits on one
ferritin shell allowed them to link with unraveled C-termini on other
shells through iron ion bridging leading to aggregation of the
homopolymers (Fig. 1c) [14]. However, mammalian ferritins are
almost exclusively heteropolymeric, and all three polypeptides (Mt-
FTL, FTH1 and Wt-FTL) are found in IBs of patients with HF and in IBs
of a transgenic animal model [8,16]. Thus, the focus of this work is toFig. 1. Ferritin structural disruption and aggregation caused byMt-FTL subunits. (a) The struc
structures of Wt- and Mt-FTL homopolymers viewed down one of their 4-fold axes. (b) Clos
remarkable disruption in Mt-FTL making the pores unstable and leaky. Note that since the l
termini are substantially longer than represented in (b), and if extended could reach as fa
homopolymers is consistent with a model in which iron binds to the unraveled and extend
initiating a gradual accumulation of ferritin and iron into a precipitate. Bridging is not neces
group and a surface amino acid which both have afﬁnity for iron. Structures were taken fro
modiﬁed from [14].determine the consequences of (i) substituting Mt-FTL in place of Wt-
FTL subunits in FTL/FTH1 24-mers and (ii) forming FTL 24-mers
composed of both Mt-FTL and Wt-FTL subunits.2. Materials and methods
2.1. Puriﬁcation, assembly and characterization of ferritin homo- and
heteropolymers
Unless speciﬁed otherwise, the reagents and buffers used in this
study were obtained from Sigma-Aldrich Chemical Company, Inc.
Mt-FTL (p.Phe167SerfsX26), FTH1 and Wt-FTL recombinant
human polypeptides were expressed and puriﬁed from BL21 (DE3)
Escherichia coli (Invitrogen) as ferritin 24-mer homopolymers as
described previously [14]. In order to produce apoferritin, iron was
removed through incubation of homopolymers with 1% thioglycollic
acid, pH 5.5, and 2,2'-bipyridine, followed by dialysis against 0.1 M
phosphate buffer, pH 7.4. The resulting apoferritin homopolymers
were dissociated into monomers and co-assembled into heteropoly-
mers as follows. Mt-FTL, FTH1, and Wt-FTL homopolymers were
equilibrated separately for 6 h with 6 M GdnHCl, pH 3.5, to ensure
complete subunit dissociation. After mixing equal molar amounts
(1 mM) of FTH1 subunits and either Mt-FTL or Wt-FTL, the solutions
were diluted with phosphate buffer (0.1 M, pH 7.4) to a ﬁnal GdnHCl
concentration below 0.6 M. After 12 h incubation at room tempera-
ture for subunit reassembly, the solutions were dialyzed overnight
against 0.1 M MOPS, pH 6.5. Reassembled 24-mers were electro-
phoresed on non-denaturing 3–8% polyacrylamide gels (Invitrogen)
and stained with Coomasie blue (Pierce). Size exclusion chromatog-
raphy elution proﬁles of the heteropolymers were obtained with a
Superose 6 10/300 GL column (GE Healthcare) equilibrated with
50 mM Tris, 150 mM NaCl, pH 7.4, using an AKTA puriﬁer system (GE
Healthcare) as described previously [14]. Protein concentration was
determined using BCA reagent (Pierce) with bovine serum albumin as
standard.ture of the spherical shell is maintained inmutant ferritin as seen in the crystallographic
e up views of the 4-fold pore from the interior of the Wt- and Mt-FTL structures show
ast 26 amino acids of Mt-FTL remained unaccounted for crystallographically, mutant C-
r as the diameter of the ferritin shell. (c) Iron loading-induced aggregation of Mt-FTL
ed portion of the mutant C-termini on two different ferritin shells bridging them and
sarily restricted to C-termini and may become more general, e.g., between a C-terminal
m RCSB (code 2FG8 for Wt-FTL and 3HX2 for Mt-FTL) and the precipitation model was
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resulting heteropolymer solubility
Freshly prepared ferrous ammoniumsulphatewas added to separate
samples of heteropolymeric or homopolymeric apoferritins in 0.1 M
MOPS, pH 6.5, and incubated for 2 h at 24 °C. The protein concentration
was 1 μM and iron concentrations were 0, 1, and 3 mM. Samples were
centrifuged for 15 min at 10,000g in order to separate soluble from
aggregatedprotein. The resulting soluble fractionswere electrophoresed
onnon-denaturing3–8%polyacrylamidegels and stainedwithCoomasie
blue, and the pellets were resuspended in Laemmli sample buffer,
electrophoresed on SDS 12% polyacrylamide gels (Pierce), and blotted
with antibodies against FTH1 (Ramco), Mt-FTL (1238), and Wt-FTL
(1277), as described previously [8].
2.3. Quantifying iron incorporation into soluble ferritin heteropolymers
Apoferritin heteropolymers were separately incubated with
ferrous ammonium sulphate in 0.1 M MOPS, pH 6.5. The protein
concentration was 1 μM and iron concentration was 1 mM. After 2 h,
incubation was stopped by the addition of HCl and bathophenanthro-
line, each to a 10 mM ﬁnal concentration. Unincorporated iron was
separated from ferritin by electrophoresis on non-denaturing 3–8%
polyacrylamide gels, and the remaining iron biomineral was quanti-
tated by Prussian blue formation within the ferritin bands [15]. The
amount of iron not incorporated into ferritin after incubation was
determined by spectroscopically measuring the iron remaining in
solution. Bathophenantholine was added to the samples after the 2 h
incubation with iron, the samples were diluted 10-fold with MOPS
buffer (0.1 M, pH 6.5), and their absorbances were read at 535 nm.
The amount of chelated Fe(II) was calculated using an extinction
coefﬁcient at 535 nm of 22140 M−1 cm−1. All data are presented as
mean±SD using independent experiments performed in triplicate.
*, pb0.01.
3. Results
3.1. Mt-FTL formed heteropolymers with either FTH1 or Wt-FTL under
routine conditions
To determine whether Mt-FTL subunits are capable of co-assembly
with FTH1 subunits into 24-mer heteropolymers, recombinant ferritin
subunits were mixed in a 1:1 ratio and put through a routine
reassembly procedure [14,15]. Native PAGE showed that Mt-FTL/FTH1
and Wt-FTL/FTH1 heteropolymers have intermediate electrophoretic
mobilities between Mt-FTL, FTH1 and Wt-FTL homopolymers, which
conﬁrmed that the individual subunits had co-assembled intoFig. 2. Formation of ferritin heteropolymers from Mt-FTL and FTH1 polypeptides. Recombin
ratio and allowed to co-assemble into heteropolymers by gradually removing GdnHCl. (a) Fiv
were resolved by 3–8% native PAGE and stained with Coomasie blue. Mt-FTL, FTH1, andWt-F
elution proﬁles of the heteropolymers were obtained with a Superose 6 10/300 GL columnheteropolymers (Fig. 2a). By gel chromatography, the two hetero-
polymers showed elution proﬁles that were almost identical with
clear, overlapping peaks indicative of ferritin 24-mer formation
(Fig. 2b). Importantly, we did not observe a peak at ~20 kDa in the
chromatograms, which would be indicative of the presence of non-
assembled subunits. In a parallel set of experiments, Mt-FTL subunits
were found to assemble in a very similar manner with Wt-FTL
subunits producing Mt-FTL/Wt-FTL heteropolymers (data not
shown).
3.2. Iron loading induced the precipitation of both Mt-FTL/FTH1 and
Mt-FTL/Wt-FTL heteropolymers
To test if the substitution of Mt-FTL for Wt-FTL subunits in
heteropolymeric ferritin can enhance susceptibility to precipitation,
we compared the solubility of Mt-FTL/FTH1 and Wt-FTL/FTH1
heteropolymers during iron loading by increasing the concentration
of iron in increments of 1000 iron atoms per ferritin molecule as
described previously [5,14,15]. Mt-FTL/FTH1 heteropolymers began to
precipitate at iron loading over 1000 atoms of iron per 24-mer, as
previously reported for Mt-FTL homopolymers [14]. Native PAGE
showed that at an iron loading of 3000 atoms of iron per 24-mer, Mt-
FTL/FTH1 heteropolymers were removed from solution by centrifu-
gation, but Wt-FTL/FTH1 heteropolymers remained soluble (Fig. 3a).
Western blot analysis of the precipitates showed the presence of Mt-
FTL and FTH1 polypeptides in the insoluble Mt-FTL/FTH1 hetero-
polymeric fraction (Fig. 3b). In a parallel experiment, iron loading of
Mt-FTL/Wt-FTL heteropolymers under the same conditions showed
precipitation by iron in a manner similar to that observed for Mt-FTL/
FTH1 heteropolymers (Fig. 3c). Western blot analysis of the resulting
insoluble fraction showed the presence of both polypeptides in the
precipitate (Fig. 3d).
3.3. Soluble Mt-FTL/FTH1 heteropolymers exhibited reduced iron
incorporation
To determine if the substitution of Mt-FTL for Wt-FTL subunits in
ferritin heteropolymers can reduce net iron incorporation, soluble Mt-
FTL/FTH1andWt-FTL/FTH1heteropolymerswere separately incubated
in a 1000:1 iron:heteropolymer ratio as describedpreviously [15]. After
non-denaturing electrophoresis and Prussian blue staining, we
observed an ~50% reduction in the amount of biomineralized iron
withinMt-FTL/FTH1heteropolymers compared to that ofWt-FTL/FTH1
heteropolymers (Fig. 4a). Moreover, the amount of free iron remaining
in solution for Mt-FTL/FTH1 heteropolymers was approximately
double of that measured for Wt-FTL/FTH1 heteropolymers (Fig. 4b)
in agreement with the biomineralized iron data.ant Mt-FTL and FTH1 (or Wt-FTL and FTH1) polypeptides (1 mM) were mixed in a 1:1
emicrograms of reassembled Mt-FTL/FTH1 orWt-FTL/FTH1 apoferritin heteropolymers
TL apoferritin homopolymers were run as controls. (b) Size exclusion chromatographic
with elution time markers for molecular weights indicated with arrows.
Fig. 3. Iron loading-induced precipitation of ferritin heteropolymers containing Mt-FTL subunits. Ferrous ammonium sulphate was added to separate samples of heteropolymeric
(Mt-FTL/FTH1, Wt-FTL/FTH1, and Mt-FTL/Wt-FTL) or homopolymeric (Mt-FTL and Wt-FTL) apoferritins, and incubated for 2 h. The protein concentration was 1 μM and iron
concentrations were 0, 1, and 3 mM. Samples were centrifuged for 15 min at 10,000g in order to separate soluble from aggregated protein. In contrast to the solubility of Wt-FTL/
FTH1 heteropolymers, precipitation of Mt-FTL/FTH1 and Mt-FTL/Wt-FTL heteropolymers was observed at 3 mM iron. (a) Soluble fractions of Mt-FTL/FTH1 and Wt-FTL/FTH1
heteropolymers were characterized by 3–8% native PAGE and stained with Coomasie blue. (b) The insoluble fraction was resuspended in Laemmli sample buffer, resolved by 12%
SDS-PAGE, and blotted with antibodies against FTH1 andMt-FTL. (c)Mt-FTL/Wt-FTL heteropolymers and the corresponding homopolymers were iron loaded and electrophoresed as
in (a) above, showing precipitation for hetero- or homopolymers containing Mt-FTL. (d) The insoluble fraction from Mt-FTL/Wt-FTL was resuspended, electrophoresed, and blotted
as in (b) above, with antibodies against Wt-FTL and Mt-FTL.
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Although the role of ferritin in iron homeostasis has been
extensively studied, the mechanism(s) by which mutant FTL poly-
peptides cause neurodegeneration is still unclear. Herein, we show
that the non-native structure of Mt-FTL subunits [14,15] does notba
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Fig. 4. Iron incorporation by soluble ferritin heteropolymers. Mt-FTL/FTH1 (M) andWt-
FTL/FTH1 (W) apoferritin heteropolymers were separately incubated with ferrous
ammonium sulphate at concentrations of 1 μM and 1 mM, respectively. After 2 h,
incubation was stopped by the addition of HCl and bathophenanthroline. (a) After
separating unincorporated iron from the protein by electrophoresis on non-denaturing
gels (3–8% native PAGE), iron biomineral within the heteropolymer interior was
quantitated as density of Prussian blue formed in the protein bands. (b) Iron
incorporation by the Mt-FTL/FTH1 heteropolymers relative to Wt-FTL/FTH1 was
determined throughmeasurement of residual ferrous iron in solution. Bathophenantho-
line was added to the samples after the 2 h incubation with iron, the samples were
diluted 10-fold with buffer, their absorbances were read at 535 nm, and the amount of
chelated Fe(II) was calculated using an extinction coefﬁcient of 22140 M-1 cm-1.prevent their co-assembly into heteropolymers with either FTH1 or
Wt-FTL subunits. However, substitution of Mt-FTL for Wt-FTL
subunits in ferritin can cause compromised function through reduced
ability of soluble ferritin to incorporate iron (a loss of normal
function) and through iron-induced aggregation during the iron
loading process (a gain of toxic function). The reduction of net iron
incorporation into soluble heteropolymers of Mt-FTL/FTH1 relative to
Wt-FTL/FTH1 is consistent with increased iron levels in HF and an HF
animal model [13,16,17], and is most likely due to structural
disruption of the normally small (or sealed) 4-fold pores in ferritin
heteropolymers, as was demonstrated crystallographically in Mt-FTL
homopolymers (Fig. 1b) [15]. In HF, loss of normal ferritin function
may lead to altered iron homeostasis and free radical formation, as
suggested bymultiple cellular markers for damage by reactive oxygen
species (ROS) found in transgenic mice overexpressing Mt-FTL [17].
Increased free iron levels would also lead to iron-dependent
upregulation of cytosolic ferritin by activation of translation of ferritin
mRNAs, culminating in intracellular accumulation of ferritin as
aggregates in the presence of iron [13].
The iron loading-induced aggregation and precipitation from
solution ofMt-FTL/FTH1 andMt-FTL/Wt-FTL heteropolymeric ferritins
are most likely due to both these 24-mers having some level of
structural disruption similar to that found in the Mt-FTL homopoly-
mers with their unraveled and extended C-terminal E helices [15].
Precipitation of the mutant-containing heteropolymers would follow
from our model for the Mt-FTL homopolymers of iron bridging
initiating at unraveled C-termini (Fig. 1c) [14]. However, the Mt-FTL/
FTH1 and Mt-FTL/Wt-FTL heteropolymeric precipitation observed
here indicates that aggregation does not require all 24 or even a
majority of the 24 subunits to be Mt-FTL. Clearly, the presence of half
Fig. 5. Altered iron metabolism and ferritin aggregation in the pathogenesis of HF. Iron
homeostasis is crucial in providing an optimum amount of iron as a cofactor for proteins
while preventing generation of ROS, which can cause damage to proteins, membranes
and DNA [1]. The cellular abnormalities associated with the FTLmutation originate in 4-
fold pore disruption and enhanced aggregation, and can be understood in terms of a
loss of normal function (left) and a gain of toxic function (right) of ferritin. Increased
cellular iron levels, up-regulation of ferritin production, and aggregation appear to
work synergistically (blue arrows) to form large nuclear and cytoplasmic IBs, perhaps
even causing cellular misfunction through mechanical crowding. Increased iron levels
may enhance ROS generation at a location separate from ferritin or as part of the
compromised iron handling and aggregation of ferritin itself (green arrows). Thus
cellular dysfunction may be a consequence of both a decrease in normal function and an
increase of toxic function of ferritin leading to neurodegeneration.
548 B.B. Muhoberac et al. / Biochimica et Biophysica Acta 1812 (2011) 544–548Wt-FTL subunits in the Mt-FTL/Wt-FTL heteropolymers was insufﬁ-
cient to prevent iron loading-induced precipitation from solution,
even though Wt-FTL subunits stabilize ferritin against elevated
temperature and denaturants [3,4] and can protect against aggrega-
tion during the iron loading process [5]. It remains to be systematically
determined what is the minimal number (per 24-mer) of Mt-FTL
subunits that can make the heteropolymers susceptible to precipita-
tion by iron. The presence of either FTH1 or Wt-FTL polypeptides in
combination with Mt-FTL polypeptides in the iron loading-induced
precipitates in vitro parallels their presence in IBs of patients with HF
and in IBs from a transgenic mouse model [8,16].
The ﬁnding that the functional problems (aggregation and reduced
iron incorporation) caused by the presence of the Mt-FTL subunits in
heteropolymeric ferritins parallel those found when examining the
difference between Mt- and Wt-FTL homopolymers is signiﬁcant. The
parallel functional problems strongly support the proposal that the
structural disruption previously characterized in Mt-FTL homopoly-
mers occurs in a similar manner and to a signiﬁcant extent in the Mt-
FTL/FTH1 and Mt-FTL/Wt-FTL heteropolymers leading to their
compromised function. Functional problems with FTH1-containing
heteropolymers may take on added importance in that they exhibit a
larger iron incorporation rate than Wt-FTL homopolymers, although
the potential importance to cellular dysfunction of cumulativeaggregation of all forms of ferritin enhanced by the mutant should
not be discounted.
The in vitro functional problems characterized here in mutant-
containing ferritin heteropolymers support a connection to demon-
strated cellular abnormalities in patients with HF and in an animal
model [8,16–18] consistent with both a loss of normal function and a
gain of toxic function of ferritin (Fig. 5). Further study of themolecular
basis of altered iron homeostasis, ferritin aggregation, and resulting
cellular dysfunction may lead to a better understanding of neurode-
generative disorders and point toward the development of forms of
therapeutic strategy.
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